{"result": {"id": "710d2e4c-7d90-4c3f-9ff4-b8ee012d890e", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Hypertension Treatment Community: SACUBITRIL/VALSARTAN, LOSARTAN, ALISKIREN, and AMLODIPINE\",\n    \"summary\": \"This community is centered around key medications used in the treatment of hypertension and heart failure, including SACUBITRIL/VALSARTAN, LOSARTAN, ALISKIREN, and AMLODIPINE. These entities are interconnected through their roles in hypertension management, their classification within specific drug classes, and their involvement in clinical trials and combinations for enhanced therapeutic outcomes. The community's structure highlights the importance of these medications in clinical practice and research.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical role these medications play in managing hypertension and heart failure, conditions with significant global health implications.\",\n    \"findings\": [\n        {\n            \"summary\": \"SACUBITRIL/VALSARTAN as an ARNI class medication\",\n            \"explanation\": \"SACUBITRIL/VALSARTAN is a combination drug classified under ARNI (Angiotensin Receptor-Neprilysin Inhibitor), used for heart failure and hypertension. Its classification underscores its innovative mechanism of action, combining the benefits of neprilysin inhibition with angiotensin receptor blockade. This dual action makes it a significant option in the treatment of heart failure, particularly in cases where traditional therapies may not suffice. [Data: Entities (1552), Relationships (1634)]\"\n        },\n        {\n            \"summary\": \"LOSARTAN's approval for pediatric use\",\n            \"explanation\": \"LOSARTAN, an angiotensin receptor blocker, has been approved by the NATIONAL MEDICAL PRODUCTS ADMINISTRATION for use in pediatric patients with hypertension. This approval highlights LOSARTAN's safety and efficacy across a broader patient demographic, expanding its therapeutic reach. The relationship between LOSARTAN and the regulatory body underscores the drug's compliance with stringent safety standards. [Data: Entities (1145), Relationships (1549)]\"\n        },\n        {\n            \"summary\": \"ALISKIREN's role as a direct renin inhibitor\",\n            \"explanation\": \"ALISKIREN stands out as a direct renin inhibitor, offering a unique mechanism of action in the treatment of hypertension. Its inclusion in the ASTRONAUT TRIAL, which evaluated its effect on mortality and heart failure readmissions, signifies its potential beyond hypertension management. The trial's focus on heart failure outcomes further emphasizes ALISKIREN's versatility and importance in cardiovascular therapeutics. [Data: Entities (1192, 2857), Relationships (2995)]\"\n        },\n        {\n            \"summary\": \"AMLODIPINE's effectiveness in bevacizumab-induced hypertension\",\n            \"explanation\": \"AMLODIPINE, a dihydropyridine calcium channel blocker, is noted for its effectiveness in managing bevacizumab-induced hypertension. This specific application highlights AMLODIPINE's role in addressing hypertension secondary to other treatments, showcasing its utility in complex clinical scenarios. Its frequent study in combination with other medications further underscores its value in achieving optimal therapeutic outcomes. [Data: Entities (1128)]\"\n        },\n        {\n            \"summary\": \"Combination therapies involving SACUBITRIL/VALSARTAN and AMLODIPINE\",\n            \"explanation\": \"The study of SACUBITRIL/VALSARTAN in combination with AMLODIPINE for treating systolic hypertension in Asian patients represents a significant area of research. This combination therapy approach aims to leverage the complementary mechanisms of action of these drugs to enhance blood pressure control. Such research underscores the ongoing efforts to optimize hypertension treatment strategies, particularly in specific patient populations. [Data: Relationships (2992)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559878, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 781, "prompt_tokens": 2490, "total_tokens": 3271, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1472}, "prompt_cache_hit_tokens": 1472, "prompt_cache_miss_tokens": 1018}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1552,SACUBITRIL/VALSARTAN,\"A combination drug (ARNI) used for heart failure and hypertension\"\"\",2\n1145,LOSARTAN,\"**LOSARTAN** is an angiotensin receptor blocker (ARB) medication primarily used for the treatment of hypertension (high blood pressure). It has been approved for use in pediatric patients for managing hypertension. Additionally, LOSARTAN has been studied in combination with other antihypertensive agents to evaluate its efficacy and potential synergistic effects in blood pressure management. As an ARB, it works by blocking the action of angiotensin II, a hormone that constricts blood vessels, thereby helping to lower blood pressure.\",3\n1192,ALISKIREN,\"Aliskiren is a direct renin inhibitor used for treating hypertension with a dosage range of 150-300 mg and a half-life of 40 hours\"\"\",5\n1128,AMLODIPINE,\"**AMLODIPINE** is a dihydropyridine calcium channel blocker (CCB) primarily used for the treatment of hypertension. It is specifically noted for its effectiveness in managing bevacizumab-induced hypertension. Amlodipine is frequently studied in combination with other medications to enhance therapeutic outcomes. As a calcium channel blocker, it works by inhibiting calcium ion influx into vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced blood pressure. Its broad application in hypertension treatment underscores its clinical significance.\",4\n2857,ASTRONAUT TRIAL,A randomized trial evaluating aliskiren's effect on mortality and heart failure readmissions,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n1634,ARNI,SACUBITRIL/VALSARTAN,Sacubitril/valsartan is an ARNI class medication,18\n1549,LOSARTAN,NATIONAL MEDICAL PRODUCTS ADMINISTRATION,The NMPA approved losartan for pediatric use,14\n1098,ALISKIREN,CALCIUM CHANNEL BLOCKERS,Both are antihypertensive agents mentioned in the document,7\n2992,AMLODIPINE,SACUBITRIL/VALSARTAN,Studied in combination for treating systolic hypertension in Asian patients,6\n2995,ALISKIREN,ASTRONAUT TRIAL,Aliskiren was the investigational drug in this heart failure outcomes trial,6\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_e6d369f2e65df4b5e8029c7ea3ba1a706ffa84c034976e475bd61d3cf5f9be3a_v2"}